Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Registration Study for Rare Type of Pulmonary Hypertension

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The knowledge on the rare type of pulmonary hypertension which can not be explained by left heart disease, respiratory disease or congenital heart disease is very limited. Investigators aim to setup a national registration study for the rare type of pulmonary hypertension, to understand the natural history, survival, progression, genetic and environmental contributions to disease.

Who May Be Eligible (Plain English)

Who May Qualify: - Participant is willing and able to give willing to sign a consent form for participation in the study. - Patients diagnosed as idiopathic pulmonary artery hypertension, hereditary pulmonary artery hypertension, hereditary hemorrhagic telangiectasia associated pulmonary artery hypertension, pulmonary veno-occlusive disease, pulmonary capillary hemangiomatosis associated pulmonary artery hypertension, cavernous transformation of portal vein associated pulmonary artery hypertension, special type of congenital heart disease associated pulmonary artery hypertension, chronic thromboembolism pulmonary hypertension. - All patients should have undergone right heart catheterization, diagnosed according to the guideline. Who Should NOT Join This Trial: The participant may not enter the study if ANY of the following apply: - Patients unwilling or unable to provide written consent for participation in the study. - Not suffering from the rare type of pulmonary artery hypertension; Inclusion criteria-Controls - Participant is willing and able to give willing to sign a consent form for participation in the study. - Self-reported to be healthy Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the study. * Patients diagnosed as idiopathic pulmonary artery hypertension, hereditary pulmonary artery hypertension, hereditary hemorrhagic telangiectasia associated pulmonary artery hypertension, pulmonary veno-occlusive disease, pulmonary capillary hemangiomatosis associated pulmonary artery hypertension, cavernous transformation of portal vein associated pulmonary artery hypertension, special type of congenital heart disease associated pulmonary artery hypertension, chronic thromboembolism pulmonary hypertension. * All patients should have undergone right heart catheterization, diagnosed according to the guideline. Exclusion Criteria: The participant may not enter the study if ANY of the following apply: * Patients unwilling or unable to provide written consent for participation in the study. * Not suffering from the rare type of pulmonary artery hypertension; Inclusion criteria-Controls * Participant is willing and able to give informed consent for participation in the study. * Self-reported to be healthy

Treatments Being Tested

OTHER

laboratory biomarker analysis

Laboratory results will be analysed to identify disease related biomarkers.

GENETIC

Genetic analysis

Gene sequencing results will be analysed to identify disease related mutations.

Locations (1)

Chinese Academy of Medical Sciences Fuwai Hospital and Peking Union Medical College Hospital
Beijing, Beijing Municipality, China